Matches in Wikidata for { <http://www.wikidata.org/entity/Q62041417> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q62041417 description "clinical trial" @default.
- Q62041417 description "ensayu clínicu" @default.
- Q62041417 description "klinisch onderzoek" @default.
- Q62041417 description "клінічне випробування" @default.
- Q62041417 description "临床试验" @default.
- Q62041417 name "This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)." @default.
- Q62041417 type Item @default.
- Q62041417 label "This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)." @default.
- Q62041417 prefLabel "This is a Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)." @default.
- Q62041417 P1050 Q62041417-8B6FF8D1-C99B-4697-A68A-98123A514685 @default.
- Q62041417 P1050 Q62041417-D5FD00D6-6F15-49E3-A5F7-9B59E0258989 @default.
- Q62041417 P1132 Q62041417-6585BDFC-C93A-4051-A1B2-DC65C20C108B @default.
- Q62041417 P1476 Q62041417-1210FDE7-EC72-4898-8B52-0F021842C091 @default.
- Q62041417 P1813 Q62041417-0CD7F2F4-15CF-4657-B2A5-C80E65985AC7 @default.
- Q62041417 P2899 Q62041417-F7B304A4-C98D-4E6B-AAF9-E315C766633C @default.
- Q62041417 P3098 Q62041417-6473F546-2CAA-4C5F-9970-9406FB8F0B3E @default.
- Q62041417 P31 Q62041417-A894DD26-3F27-49BC-86C1-811A8320CA51 @default.
- Q62041417 P580 Q62041417-0FE1C3CE-65A6-4D36-BED5-E94C17D6B9C8 @default.
- Q62041417 P582 Q62041417-7AB5D381-DAC7-43D4-9D8C-D7DBB29A308B @default.
- Q62041417 P6099 Q62041417-2D152F5E-3709-4C81-8D6A-4840EE824037 @default.
- Q62041417 P6153 Q62041417-D542F5FA-BFDC-4AF8-8ABE-9995D210344E @default.
- Q62041417 P8005 Q62041417-15ABEEAB-C391-49A4-B311-3F35E2788039 @default.
- Q62041417 P8005 Q62041417-AB2C506B-9E06-49CB-B2F5-CDCB09080FB8 @default.
- Q62041417 P8363 Q62041417-E22C9998-6A33-48E6-BC1C-261B85BFD9D8 @default.
- Q62041417 P859 Q62041417-CF401EE4-7C17-4D18-8BB3-2C9344229E13 @default.
- Q62041417 P1050 Q2298953 @default.
- Q62041417 P1050 Q341999 @default.
- Q62041417 P1132 "+471" @default.
- Q62041417 P1476 "A Randomized, Double-blind, Multi-center Study Assessing Short (16 Weeks) and Long-term Efficacy (up to 1 Year), Safety, and Tolerability of 2 Subcutaneous Secukinumab Dose Regimens in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (SUNSHINE)." @default.
- Q62041417 P1813 "SUNSHINE" @default.
- Q62041417 P2899 "+18" @default.
- Q62041417 P3098 "NCT03713619" @default.
- Q62041417 P31 Q30612 @default.
- Q62041417 P580 "2019-02-01T00:00:00Z" @default.
- Q62041417 P582 "2021-06-18T00:00:00Z" @default.
- Q62041417 P6099 Q42824827 @default.
- Q62041417 P6153 Q507154 @default.
- Q62041417 P8005 Q76649708 @default.
- Q62041417 P8005 Q76649855 @default.
- Q62041417 P8363 Q78089383 @default.
- Q62041417 P859 Q507154 @default.